Principal Investigator
Miguel Saps
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221127
Clinical Trial Summary
Evaluation of a 7-Day Therapeutic Trial Dose of Commercial Sucraid (sacrosidase) Oral Solution for Alleviating Congenital Sucrase-Isomaltase Deficiency (CSID) Symptoms in Pediatric Subjects with Low, Moderate, and Normal Sucrase Levels
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Gastroenterology
Contact Information
Study Contact
Grace Alvarez
Phone Number
+1 (305) 2434447
Email
galvarez2@miami.edu